Publications

Found 168 results
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is F  [Clear All Filters]
Journal Article
Tundo F, Avila MJ, Willard L, Fanous S, Curri C, Hussain I, Baaj AA.  2019.  Spinal alignment, surgery, and outcomes in cervical deformity: A practical guide to aid the spine surgeon. Clin Neurol Neurosurg. 185:105496.
Shin J, Forbes J, Lehner K, Tomasiewicz H, Schwartz TH, C Phillips D.  2019.  Skull Base 3D Modeling of Rigid Buttress for Gasket-Seal Closure Using Operative Endoscopic Imaging: Cadaveric Feasibility.. J Neurol Surg B Skull Base. 80(1):67-71.
Smart LR, Mangat HS, Issarow B, McClelland P, Mayaya G, Kanumba E, Gerber LM, Wu X, Peck RN, Ngayomela I et al..  2017.  Severe Traumatic Brain Injury at a Tertiary Referral Center in Tanzania: Epidemiology and Adherence to Brain Trauma Foundation Guidelines.. World Neurosurg. 105:238-248.
Boddu SR, Abramson DH, Marr BP, Francis JH, Y Gobin P.  2017.  Selective ophthalmic artery chemosurgery (SOAC) for retinoblastoma: fluoroscopic time and radiation dose parameters. A baseline study.. J Neurointerv Surg. 9(11):1107-1112.
Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D et al..  2007.  Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet. 369(9579):2097-105.
Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D et al..  2007.  Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet. 369(9579):2097-105.
Kaplitt MG, Krishna V, Eisenberg HM, W Elias J, Ghanouni P, Baltuch GH, Rezai A, Halpern CH, Dalm B, Fishman PS et al..  2024.  Safety and Efficacy of Staged, Bilateral Focused Ultrasound Thalamotomy in Essential Tremor: An Open-Label Clinical Trial. JAMA Neurol.
Fehlings MG, Badhiwala JH, Ahn H, H Farhadi F, Shaffrey CI, Nassr A, Mummaneni P, Arnold PM, W Jacobs B, K Riew D et al..  2021.  Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.. Lancet Neurol. 20(2):98-106.
Fehlings MG, Badhiwala JH, Ahn H, H Farhadi F, Shaffrey CI, Nassr A, Mummaneni P, Arnold PM, W Jacobs B, K Riew D et al..  2021.  Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.. Lancet Neurol. 20(2):98-106.
Fehlings MG, Badhiwala JH, Ahn H, H Farhadi F, Shaffrey CI, Nassr A, Mummaneni P, Arnold PM, W Jacobs B, K Riew D et al..  2021.  Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.. Lancet Neurol. 20(2):98-106.
Xiang C, Frietze KK, Bi Y, Li Y, Dal Pozzo V, Pal S, Alexander N, Baubet V, D'Acunto V, Mason CE et al..  2021.  RP58 Represses Transcriptional Programs Linked to Nonneuronal Cell Identity and Glioblastoma Subtypes in Developing Neurons.. Mol Cell Biol. 41(7):e0052620.
Fukuda H, Evins AI, Iwasaki K, Hattori I, Murao K, Kurosaki Y, Chin M, Stieg PE, Yamagata S, Bernardo A.  2017.  The role of alternative anastomosis sites in occipital artery-posterior inferior cerebellar artery bypass in the absence of the caudal loop using the far-lateral approach.. J Neurosurg. 126(2):634-644.
Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, Lantos J, Schenck EJ, Goyal P, Bruce SS et al..  2020.  Risk of Ischemic Stroke in Patients with Covid-19 versus Patients with Influenza.. medRxiv.
Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, Lantos J, Schenck EJ, Goyal P, Bruce SS et al..  2020.  Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza.. JAMA Neurol.
Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Ghose S, Vernov M, Stavarache M, Musatov S, Flajolet M et al..  2010.  Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med. 2(54):54ra76.
Gokaslan ZL, Bydon M, De la Garza-Ramos R, Smith ZA, Hsu WK, Qureshi SA, Cho SK, Baird EO, Mroz TE, Fehlings M et al..  2017.  Recurrent Laryngeal Nerve Palsy After Cervical Spine Surgery: A Multicenter AOSpine Clinical Research Network Study.. Global Spine J. 7(1 Suppl):53S-57S.
Ailon T, Smith JS, Nassr A, Smith ZA, Hsu WK, Fehlings MG, Fish DE, Wang JC, Hilibrand AS, Mummaneni PV et al..  2017.  Rare Complications of Cervical Spine Surgery: Pseudomeningocoele.. Global Spine J. 7(1 Suppl):109S-114S.
Ailon T, Smith JS, Nassr A, Smith ZA, Hsu WK, Fehlings MG, Fish DE, Wang JC, Hilibrand AS, Mummaneni PV et al..  2017.  Rare Complications of Cervical Spine Surgery: Pseudomeningocoele.. Global Spine J. 7(1 Suppl):109S-114S.
Traynelis VC, Malone HR, Smith ZA, Hsu WK, Kanter AS, Qureshi SA, Cho SK, Baird EO, Isaacs RE, Rahman R'KK et al..  2017.  Rare Complications of Cervical Spine Surgery: Horner's Syndrome.. Global Spine J. 7(1 Suppl):103S-108S.
Lange KRae, Fischer C, Rajappa P, Connors S, Pisapia D, Greenfield JP, Beltran H, Rubin M, Mosquera JMiguel, Khakoo Y.  2018.  Rapid autopsy of a patient with recurrent anaplastic ependymoma.. Palliat Support Care. 16(2):238-242.
Ramakrishna R, Formenti S.  2019.  Radiosurgery and Immunotherapy in the Treatment of Brain Metastases.. World Neurosurg. 130:615-622.
Strahle JM, Taiwo R, Averill C, Torner J, Shannon CN, Bonfield CM, Tuite GF, Bethel-Anderson T, Rutlin J, Brockmeyer DL et al..  2019.  Radiological and clinical predictors of scoliosis in patients with Chiari malformation type I and spinal cord syrinx from the Park-Reeves Syringomyelia Research Consortium.. J Neurosurg Pediatr. :1-8.
Younus I, Forbes JA, Ordóñez-Rubiano EG, Avendano-Pradel R, La Corte E, Anand VK, Schwartz TH.  2018.  Radiation therapy rather than prior surgery reduces extent of resection during endonasal endoscopic reoperation for craniopharyngioma.. Acta Neurochir (Wien). 160(7):1425-1431.
Nagoshi N, Fehlings MG, Nakashima H, Tetreault L, Gum JL, Smith ZA, Hsu WK, Tannoury CA, Tannoury T, Traynelis VC et al..  2017.  Prevalence and Outcomes in Patients Undergoing Reintubation After Anterior Cervical Spine Surgery: Results From the AOSpine North America Multicenter Study on 8887 Patients.. Global Spine J. 7(1 Suppl):96S-102S.
Ordóñez-Rubiano EG, Forbes JA, Morgenstern PF, Arko L, Dobri GA, Greenfield JP, Souweidane MM, Tsiouris AJohn, Anand VK, Kacker A et al..  2018.  Preserve or sacrifice the stalk? Endocrinological outcomes, extent of resection, and recurrence rates following endoscopic endonasal resection of craniopharyngiomas. J Neurosurg. :1-9.